Translational Development Acquisition Corp. (TDAC) - Dilution Analysis

8-K filing: Translational Development Acquisition Corp. entered into a subscription agreement to issue 5,000,000 Class A ordinary shares and 5,000,000 warrants for $50,000,000 in connection with a proposed business combination. ($50.0M proceeds)

8-K filing: Translational Development Acquisition Corp. issued 4,657,499 Class A ordinary shares to its sponsor through the conversion of an equivalent number of Class B ordinary shares.

10-K filing | 17.3M shares outstanding

10-Q filing | 17.3M shares outstanding

10-Q filing | 17.3M shares outstanding

10-K filing | 4.7M shares outstanding

8-K filing: Translational Development Acquisition Corp. consummated its initial public offering of 17,250,000 units at $10.00 per unit, generating gross proceeds of $172,500,000, and completed the private placement of 7,075,000 warrants to the Sponsor and the Underwriter at $1.00 per warrant, for gross proceeds of $7,075,000. ($179.58M proceeds)

S-1/A filing: Initial public offering of units by Translational Development Acquisition Corp., a blank check company, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, along with a concurrent private placement of warrants.

S-1/A filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, in an initial public offering.

S-1 filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, along with private placement warrants to be purchased by the sponsor and BTIG, LLC.

S-1 filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit for a total of $150,000,000 in an initial public offering. Each unit consists of one ordinary share and one-half of one redeemable warrant.